Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
Langley
J
J
Methodist Medical Center of Dallas, Texas.
Dickerman
R
R
Vergne-Marini
P
P
Williams
J
J
Jensik
S
S
Kenyon
N
N
Anderson
J
J
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016827:CD8 Antigens / Q000276:immunology; D005434:Flow Cytometry / Q000379:methods; D006084:Graft Rejection / Q000097:blood / Q000175:diagnosis / Q000276:immunology*; D006801:Humans; D007376:Interleukin-2 / Q000096:biosynthesis*; D016030:Kidney Transplantation / Q000276:immunology*; D015166:Monitoring, Immunologic / Q000379:methods; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012016:Reference Values; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016827:CD8 Antigens; D007376:Interleukin-2; D016853:Muromonab-CD3